Simplex Trading
HRTX icon

Simplex Trading’s Heron Therapeutics HRTX Stock Holding History

Simplex Trading’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2K Sell
12,774
-101,830
-89% -$118K ﹤0.01% 7340
2025
Q4 		$149K Buy
114,604
+87,734
+327% +$108K ﹤0.01% 4539
2025
Q3 		$33K Sell
26,870
-35,590
-57% -$56.4K ﹤0.01% 6879
2025
Q2 		$129K Buy
+62,460
New +$128K ﹤0.01% 4976
2025
Q1 		– Sell
-7,498
Closed -$14.6K – 8961
2024
Q4 		$11K Sell
7,498
-4,498
-37% -$7.29K ﹤0.01% 7124
2024
Q3 		$23K Sell
11,996
-83,635
-87% -$200K ﹤0.01% 6554
2024
Q2 		$334K Buy
+95,631
New +$294K ﹤0.01% 4104
2024
Q1 		– Sell
-20,598
Closed -$51.8K – 9264
2023
Q4 		$35K Buy
+20,598
New +$22.7K ﹤0.01% 6425
2023
Q3 		– Sell
-9,224
Closed -$13.1K – 9125
2023
Q2 		$10K Buy
9,224
+7,461
+423% +$13.3K ﹤0.01% 7400
2023
Q1 		$2K Sell
1,763
-26,872
-94% -$67.3K ﹤0.01% 8463
2022
Q4 		$71K Buy
28,635
+7,511
+36% +$24.2K ﹤0.01% 5456
2022
Q3 		$89K Buy
21,124
+2,223
+12% +$8.7K ﹤0.01% 5676
2022
Q2 		$52K Buy
+18,901
New +$75.9K ﹤0.01% 6435
2022
Q1 		– Sell
-38,853
Closed -$284K – 10811
2021
Q4 		$354K Buy
38,853
+36,847
+1,837% +$376K ﹤0.01% 4317
2021
Q3 		$30K Buy
+2,006
New +$24.4K ﹤0.01% 8084
2021
Q2 		– Sell
-64,103
Closed -$1.02M – 10296
2021
Q1 		$1.04M Buy
+64,103
New +$1.14M ﹤0.01% 2345
2020
Q4 		– Sell
-7,745
Closed -$135K – 8637
2020
Q3 		$114K Buy
7,745
+7,662
+9,231% +$120K ﹤0.01% 4761
2020
Q2 		$1K Sell
83
-52,172
-100% -$857K ﹤0.01% 7370
2020
Q1 		$613K Buy
52,255
+39,204
+300% +$737K ﹤0.01% 2381
2019
Q4 		$306K Sell
13,051
-32,164
-71% -$712K ﹤0.01% 3271
2019
Q3 		$836K Buy
45,215
+25,692
+132% +$473K ﹤0.01% 2112
2019
Q2 		$362K Buy
19,523
+10,391
+114% +$208K ﹤0.01% 2887
2019
Q1 		$223K Buy
9,132
+5,870
+180% +$154K ﹤0.01% 3486
2018
Q4 		$84K Buy
3,262
+801
+33% +$22K ﹤0.01% 4008
2018
Q3 		$77K Sell
2,461
-35,489
-94% -$1.32M ﹤0.01% 4714
2018
Q2 		$1.47M Buy
37,950
+30,041
+380% +$956K 0.01% 1405
2018
Q1 		$218K Buy
+7,909
New +$179K 0.01% 1179
2017
Q3 		– Sell
-58,262
Closed -$914K – 6188
2017
Q2 		$806K Buy
+58,262
New +$844K 0.04% 447
2017
Q1 		– Sell
-2,067
Closed -$28.6K – 6402
2016
Q4 		$27K Buy
+2,067
New +$32.4K ﹤0.01% 2759
2016
Q3 		– Sell
-15,266
Closed -$283K – 6055
2016
Q2 		$275K Buy
15,266
+3,310
+28% +$64.6K 0.02% 816
2016
Q1 		$227K Buy
11,956
+9,331
+355% +$184K 0.02% 809
2015
Q4 		$70K Sell
2,625
-16,027
-86% -$429K 0.01% 1641
2015
Q3 		$455K Buy
18,652
+16,552
+788% +$552K 0.03% 481
2015
Q2 		$65K Buy
2,100
+136
+7% +$2.56K 0.01% 1501
2015
Q1 		$28K Buy
+1,964
New +$22.1K ﹤0.01% 2034

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Simplex Trading's HRTX Position: Q1 2026 in Review

Simplex Trading reduced its Heron Therapeutics (HRTX) stake by 89% in Q1 2026, selling an estimated $118K and leaving 12,774 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #7340.

Simplex Trading first reported a position in HRTX in Q1 2015 and has held it in 35 quarters since. The position peaked at $1.47M in Q2 2018. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • Simplex Trading held 12,774 shares of Heron Therapeutics worth $10.2K as of Q1 2026.
  • Simplex Trading sold 101,830 Heron Therapeutics shares in Q1 2026, an estimated $118K.
  • Heron Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7340 holding.
  • Simplex Trading first reported a position in Heron Therapeutics in Q1 2015 and has held it in 35 quarters since.
  • Simplex Trading's Heron Therapeutics position peaked at $1.47M in Q2 2018.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.